Skip to main content
Cardiovascular Diagnosis and Therapy logoLink to Cardiovascular Diagnosis and Therapy
. 2023 Jul 25;13(4):762. doi: 10.21037/cdt-2023-5

Retraction: differential efficacy profile of aldosterone receptor antagonists, depending on the type of chronic heart failure, whether with reduced or preserved left ventricular ejection fraction—results of a meta-analysis of randomized controlled trials

Editorial Office1
PMCID: PMC10478023  PMID: 37675089

Recently, we found that the content of the paper entitled “Differential efficacy profile of aldosterone receptor antagonists, depending on the type of chronic heart failure, whether with reduced or preserved left ventricular ejection fraction—results of a meta-analysis of randomized controlled trials” (1) published in the Vol 7, No 3 (June 16, 2017) issue of Cardiovascular Diagnosis and Therapy overlapped significantly to the article “The Impact Exerted on Clinical Outcomes of Patients With Chronic Heart Failure by Aldosterone Receptor Antagonists: A Meta-Analysis of Randomized Controlled Trials” published in the Volume 9, Number 2 (February 2017) issue of the Journal of Clinical Medicine Research. The editorial office suspects that the articles are duplicate publications and thus decided to retract this paper in accordance with the journal’s retraction policy. The authors were invited to comment on this issue and subsequently informed about the decision by the editorial office.

References

  • 1.De Vecchis R, Ariano C. Differential efficacy profile of aldosterone receptor antagonists, depending on the type of chronic heart failure, whether with reduced or preserved left ventricular ejection fraction—results of a meta-analysis of randomized controlled trials. Cardiovasc Diagn Ther 2017;7:272-87. 10.21037/cdt.2017.03.04 [DOI] [PMC free article] [PubMed] [Google Scholar] [Retracted]

Articles from Cardiovascular Diagnosis and Therapy are provided here courtesy of AME Publications

RESOURCES